Sommaire

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A6

    
• • ·Information for Readers

    Page :A7

    
• • ·Correction

    Page :604

    
• • ·Correction

    Page :604

    

• Editorial

  • ·Regional systems of care for ST-elevation myocardial infarction: Do they save lives?

    Page :389-391

    Timothy D. Henry, Alice K. Jacobs, Christopher B. Granger

    

• Progress in Cardiology

  • ·Exercise-mediated changes in high-density lipoprotein: Impact on form and function

    Page :392-400

    Alisa Blazek, Jessica Rutsky, Kwame Osei, Andrei Maiseyeu, Sanjay Rajagopalan

    Résumé Résumé Plan Plan  

• Curriculum in Cardiology

  • ·Differences in the outcome of patients undergoing percutaneous coronary interventions at teaching versus non-teaching hospitals

    Page :401-408

    Amneet Sandhu, Mauro Moscucci, Simon Dixon, David H. Wohns, David Share, Thomas LaLonde, Dean Smith, Hitinder S. Gurm

    Résumé Résumé Plan Plan  
  • ·The left bundle-branch block puzzle in the 2013 ST-elevation myocardial infarction guideline: From falsely declaring emergency to denying reperfusion in a high-risk population. Are the Sgarbossa Criteria ready for prime time?

    Page :409-413

    Qiangjun Cai, Nilay Mehta, Elena B. Sgarbossa, Sergio L. Pinski, Galen S. Wagner, Robert M. Califf, Alejandro Barbagelata

    Résumé Résumé Plan Plan  

• Results of Expert Meetings

  • ·Overview of the 2012 Food and Drug Administration circulatory system devices panel meeting on the reclassification of external counterpulsation, intra-aortic balloon pump, and non–roller-type cardiopulmonary bypass blood pump devices

    Page :414-420

    Sa'ar Minha, Omid Fatemi, Rebecca Torguson, Ron Waksman

    Résumé Résumé Plan Plan

• Trial Design

  • ·Embedding a randomized clinical trial into an ongoing registry infrastructure: Unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women)

    Page :421

    Connie N. Hess, Sunil V. Rao, David F. Kong, Laura H. Aberle, Kevin J. Anstrom, C. Michael Gibson, Ian C. Gilchrist, Alice K. Jacobs, Sanjit S. Jolly, Roxana Mehran, John C. Messenger, L. Kristin Newby, Ron Waksman, Mitchell W. Krucoff

    Résumé Résumé Plan Plan  
  • ·Evaluation of the dual peroxisome proliferator–activated receptor ?/? agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: Rationale and design of the AleCardio trial

    Page :429

    A. Michael Lincoff, Jean-Claude Tardif, Bruce Neal, Stephen J. Nicholls, Lars Rydén, Gregory G. Schwartz, Klas Malmberg, John B. Buse, Robert R. Henry, Hans Wedel, Arlette Weichert, Ruth Cannata, Diederick E. Grobbee

    Résumé Résumé Plan Plan
  • ·Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial

    Page :435

    Stephen E. Kimmel, Benjamin French, Jeffrey L. Anderson, Brian F. Gage, Julie A. Johnson, Yves D. Rosenberg, Nancy L. Geller, Scott E. Kasner, Charles S. Eby, Jungnam Joo, Michael D. Caldwell, Samuel Z. Goldhaber, Robert G. Hart, Denise Cifelli, Rosemary Madigan, Colleen M. Brensinger, Suzanne Goldberg, Robert M. Califf, Jonas H. Ellenberg

    Résumé Résumé Plan Plan  
  • ·Improving outcomes in patients with atrial fibrillation: Rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial

    Page :442-448

    Paulus Kirchhof, Günter Breithardt, A. John Camm, Harry J. Crijns, Karl-Heinz Kuck, Panos Vardas, Karl Wegscheider

    Résumé Résumé Plan Plan  
  • ·The Coronary Artery Disease and Renal Failure (CAD-REF) registry: Trial design, methods, and aims

    Page :449

    Eva Brand, Hermann Pavenstädt, Roland E. Schmieder, Christiane Engelbertz, Manfred Fobker, Hans O. Pinnschmidt, Karl Wegscheider, Günter Breithardt, Holger Reinecke

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·A prospective regional registry of ST-elevation myocardial infarction in Central Romania: Impact of the Stent for Life Initiative recommendations on patient outcomes

    Page :457-465

    Imre Benedek, Mariann Gyongyosi, Theodora Benedek

    Résumé Résumé Plan Plan  
  • ·Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non–ST-segment elevation acute coronary syndromes patients: An analysis from the Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome trial

    Page :466

    Akshay Bagai, Jennifer A. White, Yuliya Lokhnygina, Robert P. Giugliano, Frans Van de Werf, Gilles Montalescot, Paul W. Armstrong, Pierluigi Tricoci, C. Michael Gibson, Robert M. Califf, Robert A. Harrington, L. Kristin Newby

    Résumé Résumé Plan Plan  
  • ·Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: Insights from the PLATelet inhibition and patient outcomes (PLATO) trial

    Page :474-480

    Emmanouil S. Brilakis, Claes Held, Bernhard Meier, Frank Cools, Marc J. Claeys, Jan H. Cornel, Philip Aylward, Basil S. Lewis, Douglas Weaver, Gunnar Brandrup-Wognsen, Susanna R. Stevens, Anders Himmelmann, Lars Wallentin, Stefan K. James

    Résumé Résumé Plan Plan  
  • ·Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: Assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial

    Page :481-487

    G.B. John Mancini, Pamela M. Hartigan, Eric R. Bates, Bernard R. Chaitman, Steven P. Sedlis, David J. Maron, William J. Kostuk, John A. Spertus, Koon K. Teo, Marcin Dada, Merril Knudtson, Daniel S. Berman, David C. Booth, William E. Boden, William S. Weintraub

    Résumé Résumé Plan Plan  
  • ·Race, exercise training, and outcomes in chronic heart failure: Findings from Heart Failure - A Controlled Trial Investigating Outcomes in Exercise TraiNing (HF-ACTION)

    Page :488

    Robert J. Mentz, Vera Bittner, Phillip J. Schulte, Jerome L. Fleg, Ileana L. Piña, Steven J. Keteyian, Gordon Moe, Anil Nigam, Ann M. Swank, Anekwe E. Onwuanyi, Meredith Fitz-Gerald, Andrew Kao, Stephen J. Ellis, William E. Kraus, David J. Whellan, Christopher M. O'Connor

    Résumé Résumé Plan Plan  
  • ·Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: Patient outcomes, rate of appropriate and inappropriate interventions, and complications

    Page :496-502

    Pieter A. Vriesendorp, Arend F.L. Schinkel, Johan Van Cleemput, Rik Willems, Luc J.L.M. Jordaens, Dominic A.M.J. Theuns, Marjon A. van Slegtenhorst, Thomy J. de Ravel, Folkert J. ten Cate, Michelle Michels

    Résumé Résumé Plan Plan  
  • ·Association between septal strain rate and histopathology in symptomatic hypertrophic cardiomyopathy patients undergoing septal myectomy

    Page :503-511

    Taisei Kobayashi, Zoran Popovic, Aditya Bhonsale, Nicholas G. Smedira, Carmela Tan, E. Rene Rodriguez, Maran Thamilarasan, Bruce W. Lytle, Harry M. Lever, Milind Y. Desai

    Résumé Résumé Plan Plan  
  • ·Morbidity in children and adolescents after surgical correction of truncus arteriosus communis

    Page :512-518

    Michael L. O'Byrne, Laura Mercer-Rosa, Huaqing Zhao, Xuemei Zhang, Wei Yang, Amy Cassedy, Mark A. Fogel, Jack Rychik, Ronn E. Tanel, Bradley S. Marino, Stephen Paridon, Elizabeth Goldmuntz

    Résumé Résumé Plan Plan
  • ·Change in enrollment patterns, patient selection, and clinical outcomes with the availability of drug-eluting stents in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial

    Page :519

    Binita Shah, Vankeepuram S. Srinivas, Jiang Lu, Maria M. Brooks, Eric R. Bates, Zoran S. Nedeljkovic, Jorge Escobedo, Gladwin S. Das, John J. Lopez, Frederick Feit

    Résumé Résumé Plan Plan  
  • ·A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis

    Page :527

    Seiji Habara, Masashi Iwabuchi, Naoto Inoue, Shigeru Nakamura, Ryuta Asano, Shinsuke Nanto, Yasuhiko Hayashi, Nobuo Shiode, Shigeru Saito, Yuji Ikari, Takeshi Kimura, Joji Hosokawa, Masato Nakamura, Jun-ichi Kotani, Ken Kozuma, Kazuaki Mitsudo

    Résumé Résumé Plan Plan  
  • ·Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy

    Page :534-540

    Gjin Ndrepepa, Stefanie Schulz, Franz-Josef Neumann, Robert A. Byrne, Petra Hoppmann, Salvatore Cassese, Ilka Ott, Massimiliano Fusaro, Tareq Ibrahim, Tomohisa Tada, Gert Richardt, Karl-Ludwig Laugwitz, Heribert Schunkert, Adnan Kastrati

    Résumé Résumé Plan Plan  
  • ·High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men

    Page :541

    Kai M. Eggers, Jinan Al-Shakarchi, Lars Berglund, Bertil Lindahl, Agneta Siegbahn, Lars Wallentin, Björn Zethelius

    Résumé Résumé Plan Plan  
  • ·Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: Results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

    Page :549-558

    David A. Garcia, Lars Wallentin, Renato D. Lopes, Laine Thomas, John H. Alexander, Elaine M. Hylek, Jack Ansell, Michael Hanna, Fernando Lanas, Greg Flaker, Patrick Commerford, Denis Xavier, Dragos Vinereanu, Hongqiu Yang, Christopher B. Granger

    Résumé Résumé Plan Plan  
  • ·Documentation of study medication dispensing in a prospective large randomized clinical trial: Experiences from the ARISTOTLE Trial

    Page :559

    John H. Alexander, Elliott Levy, Jack Lawrence, Michael Hanna, Anthony P. Waclawski, Junyuan Wang, Robert M. Califf, Lars Wallentin, Christopher B. Granger

    Résumé Résumé Plan Plan  
  • ·African American race but not genome-wide ancestry is negatively associated with atrial fibrillation among postmenopausal women in the Women's Health Initiative

    Page :566

    Marco V. Perez, Thomas J. Hoffmann, Hua Tang, Timothy Thornton, Marcia L. Stefanick, Joseph C. Larson, Charles Kooperberg, Alex P. Reiner, Bette Caan, Carlos Iribarren, Neil Risch

    Résumé Résumé Plan Plan  
  • ·Burden, timing, and relationship of cardiovascular hospitalization to mortality among Medicare beneficiaries with newly diagnosed atrial fibrillation

    Page :573-580

    Mintu P. Turakhia, Matthew D. Solomon, Mehul Jhaveri, Pamela Davis, Michael R. Eber, Ryan Conrad, Nicholas Summers, Darius Lakdawalla

    Résumé Résumé Plan Plan  
  • ·Appropriate test selection for single-photon emission computed tomography imaging: Association with clinical risk, posttest management, and outcomes

    Page :581-588

    Nael Aldweib, Kazuaki Negishi, Sinziana Seicean, Wael A. Jaber, Rory Hachamovitch, Manuel Cerqueira, Thomas H. Marwick

    Résumé Résumé Plan Plan  
  • ·Predictors of discordance between physicians' and patients' appraisals of health-related quality of life in atrial fibrillation patients: Findings from the Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation Trial

    Page :589

    Alexander von Eisenhart Rothe, Mona Bielitzer, Thomas Meinertz, Tobias Limbourg, Karl-Heinz Ladwig, Andreas Goette

    Résumé Résumé Plan Plan  
  • ·Treatment strategies in patients with statin intolerance: The Cleveland Clinic experience

    Page :597-603

    Warner M. Mampuya, David Frid, Michael Rocco, Julie Huang, Danielle M. Brennan, Stanley L. Hazen, Leslie Cho

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Renal dysfunction may predict new onset heart failure

    Page :e5

    Sevket Balta, Sait Dem?rkol, Murat Karaman

    
  • ·Response to letter by Balta et al regarding “Renal dysfunction and long-term risk of heart failure after coronary artery bypass grafting”

    Page :e7

    Martin J. Holzmann, Ulrik Sartipy

    
  • ·Letter to the Editor regarding “Assessment of drug-induced increases in blood pressure during drug development: Report from the Cardiac Safety Research Consortium”

    Page :e9

    Robert P. Blankfield

    
  • ·Response to Letter to the Editor by Blankfield regarding “Assessment of drug-induced increases in blood pressure during drug development: Report from the Cardiac Safety Research Consortium.”

    Page :e11

    William B. White, Philip T. Sager

    
  • ·Exercise-induced pulmonary hypertension in systemic sclerosis: A multifactorial entity

    Page :e13

    Rui Baptista, Rogério Teixeira

    
  • ·Response to Letter to the Editor by Rui Baptista, M.D., Rogério Teixeira, M.D.

    Page :e15

    Luna Gargani, Gergely Agoston, Alberto Moggi Pignone, Antonella Moreo, Luigi P. Badano, Laura Bazzichi, Marco Fabio Costantino, Francesco Pieri, Oscar Epis, Eleonora Bruschi, Benedetta De Chiara, Fabio Mori, Stefano Bombardieri, Marco Matucci Cerinic, Eduardo Bossone, Eugenio Picano

    
  • ·The need to know crude event rates in meta-analysis

    Page :e17

    Andrea Messori, Valeria Fadda, Dario Maratea, Sabrina Trippoli

    
  • ·Response to letter by Messeri et al

    Page :e19

    Tullio Palmerini, Giuseppe Biondi-Zoccai, Diego Della Riva, Andrea Mariani, Gregg W. Stone